Answers are grounded in this paper and cite their sources.
This document provides the new EANM guideline on radioiodine therapy of benign thyroid disease. Its aim is to guide nuclear medicine physicians, endocrinologists, and practitioners in the selection of patients for radioiodine therapy. Its recommendations on patients' preparation, empiric and dosimetric therapeutic approaches, applied radioiodine activity, radiation protection requirements, and patients follow-up after administration of radioiodine therapy are extensively discussed.
No takes yet. Share an insight, caveat, or question.
Campennì et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: